Ascendis Pharma A/S ASND
$ 136.02
-1.25%
Annual report 2023
added 12-14-2024
Country |
Danmark |
IPO year |
2015 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Jan Moeller Mikkelsen |
Employees in the company |
330 |
Shares |
- |
Market Cap[1] |
$ 5 B |
EBITDA (LTM) |
$ -467 M |
P/E (LTM) |
-14.98 |
P/S (LTM) |
657.11 |
EPS (LTM) |
-7.45 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.